Function Therapeutics receives SBIR award to study potential treatment for liver disease (MASH)
Function Therapeutics has been awarded a Phase 1 Small Business Innovation Research (SBIR) grant from the National Institute of Diabetes...
top of page
NEWS
Announcements & Discoveries
Oct 19
Parmodulin shows beneficial effects in obese mice
In the Journal of Thrombosis and Haemostasis, the lab of Dr. James Luyendyk (Michigan State University) and colleagues reported the...
Jun 4
Function Therapeutics receives SBIR award to study acute kidney injury (AKI)
Function Therapeutics has been awarded a Phase 1 Small Business Innovation Research (SBIR) grant from the National Institute of Diabetes...
Sep 21, 2023
Function Therapeutics receives Phase 1 SBIR Award from NIH (NHLBI)
Function Therapeutics has been awarded a Phase 1 Small Business Innovation Research (SBIR) grant from the National Heart, Lung, and Blood...
For News Inquiries
bottom of page